Nucleic Acid Detection Technologies--Labels, Strategies, And Formats. Nucleic Acid Detection Technologies--Labels, Strategies, And Formats.

Nucleic Acid Detection Technologies--Labels, Strategies, And Formats‪.‬

Clinical Chemistry 1999, April, 45, 4

    • €2.99
    • €2.99

Publisher Description

The range and scope of nucleic acid-based assays continues to expand (e.g., medical, forensic, and environmental applications) (1-3). Many of the types of nucleic acid assays developed require a secondary detection technology, e.g., a label, because a nucleic acid does not have intrinsic properties that are useful for direct high-sensitivity detection. As yet there is no consensus on the choice of a label for nucleic acid detection, and none of the current labels has the attributes of a universal or ideal label. Key factors governing label choice include stability, sensitivity of detection, speed and convenience of detection, and the overall cost for the label, detection reagents, and detection system. In addition, modulation of a property of a label when a conjugate binds to a binding molecule is also desirable because it can form the basis of nonseparation assays. Two new analytical formats, the microchip and the microarray, pose new challenges for nucleic acid detection (4-6). Here I review current directions in nucleic acid analysis and discusses recent strategies for ultrasensitive detection (Table 1). Labels and Sensitivity

GENRE
Science & Nature
RELEASED
1999
1 April
LANGUAGE
EN
English
LENGTH
19
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
185.5
KB
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)
2006
Molecular Biomethods Handbook Molecular Biomethods Handbook
2008
Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials) Multiplex Assays with Fluorescent Microbead Readout: A Powerful Tool, For Mutation Detection (Editorials)
2004
Pcr-Oligonucleotide Ligation Assay from Dried Blood Spots (Technical Briefs) Pcr-Oligonucleotide Ligation Assay from Dried Blood Spots (Technical Briefs)
1999
Aptamers for Analytical Applications Aptamers for Analytical Applications
2018
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003